BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335:1570-1580. [PMID: 8900092 DOI: 10.1056/nejm199611213352107] [Cited by in Crossref: 364] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Kouroumalis E, Notas G. Pathogenesis of primary biliary cirrhosis: A unifying model. World J Gastroenterol 2006; 12(15): 2320-2327 [PMID: 16688819 DOI: 10.3748/wjg.v12.i15.2320] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ni P, Men R, Shen M, Wang T, Huang C, Fan X, Yang L. Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis. Can J Gastroenterol Hepatol 2019;2019:7396870. [PMID: 31275901 DOI: 10.1155/2019/7396870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Oo YH, Neuberger J. HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: a new piece in the jigsaw? Liver Transpl 2007;13:8-13. [PMID: 17192903 DOI: 10.1002/lt.20890] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Lazarczyk DA, Duffy MC. Erythromycin-induced primary biliary cirrhosis. Dig Dis Sci 2000;45:1115-8. [PMID: 10877225 DOI: 10.1023/a:1005589616735] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang Z, Yin H, Lau CS, Lu Q. Histone Posttranslational Modifications of CD4⁺ T Cell in Autoimmune Diseases. Int J Mol Sci 2016;17:E1547. [PMID: 27669210 DOI: 10.3390/ijms17101547] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hu CJ, Li YZ, Zhao GF, Li N, Xu Y, Tong DW, Zhang SL. Screening for specific biomarkers in serum for diagnosis of primary biliary cirrhosis using proteomic fingerprint technology. Shijie Huaren Xiaohua Zazhi 2008; 16(3): 277-283 [DOI: 10.11569/wcjd.v16.i3.277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Invernizzi P, Battezzati PM, Crosignani A, Zermiani P, Bignotto M, Del Papa N, Zuin M, Podda M. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol. 1998;114:448-454. [PMID: 9844056 DOI: 10.1046/j.1365-2249.1998.00735.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
8 Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S, Granito A, Cassani F, Loria P, Lenzi M. ‘True’ antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004;135:154-158. [PMID: 14678277 DOI: 10.1111/j.1365-2249.2004.02332.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 3.7] [Reference Citation Analysis]
9 Bloch DB, Chiche JD, Orth D, de la Monte SM, Rosenzweig A, Bloch KD. Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol 1999;19:4423-30. [PMID: 10330182 DOI: 10.1128/MCB.19.6.4423] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
10 Selmi C, Zuin M, Gershwin ME. The unfinished business of primary biliary cirrhosis. J Hepatol 2008;49:451-60. [PMID: 18640737 DOI: 10.1016/j.jhep.2008.06.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
11 Sasaki M, Ikeda H, Sawada S, Sato Y, Nakanuma Y. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis. J Clin Pathol 2007;60:1102-7. [PMID: 17158635 DOI: 10.1136/jcp.2006.044776] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
12 Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001;108:223-232. [PMID: 11457875 DOI: 10.1172/jci10716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 69] [Article Influence: 0.2] [Reference Citation Analysis]
13 Sakauchi F, Mori M, Zeniya M, Toda G. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2006;16:30-34. [PMID: 16369106 DOI: 10.2188/jea.16.30] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
14 Lal SK, Pedrosa M, Orlander J, Klein MA. Primary biliary cirrhosis in an 86-year-old male. Dig Dis Sci 2003;48:1627-9. [PMID: 12924659 DOI: 10.1023/a:1024736411854] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases. Dig Dis Sci 2001;46:2043-7. [PMID: 11575461 DOI: 10.1023/a:1010620122567] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
16 von Schönfeld J, Breuer N, Goebell H. [Primary biliary cirrhosis: diagnosis and therapy]. Med Klin (Munich) 1998;93:627-8. [PMID: 9849055 DOI: 10.1007/BF03042679] [Reference Citation Analysis]
17 De Smet PA. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997;54:801-40. [PMID: 9421691 DOI: 10.2165/00003495-199754060-00003] [Cited by in Crossref: 136] [Cited by in F6Publishing: 98] [Article Influence: 5.7] [Reference Citation Analysis]
18 Masuda J, Omagari K, Ohba K, Hazama H, Kadokawa Y, Kinoshita H, Hayashida K, Hayashida K, Ishibashi H, Nakanuma Y, Kohno S. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis. Dig Dis Sci 2003;48:932-8. [PMID: 12772793 DOI: 10.1023/a:1023055714208] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol 2009; 15(8): 897-906 [PMID: 19248187 DOI: 10.3748/wjg.15.897] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
20 Alempijevic T, Krstic M, Jesic R, Jovanovic I, Milutinovic AS, Kovacevic N, Krstic S, Popovic D. Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis. World J Gastroenterol 2009; 15(5): 591-594 [PMID: 19195061 DOI: 10.3748/wjg.15.591] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
21 Sakauchi F, Mori M, Zeniya M, Toda G. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2005;15:24-28. [PMID: 15678923 DOI: 10.2188/jea.15.24] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
22 Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis. Dig Dis Sci 2014;59:358-64. [PMID: 24185682 DOI: 10.1007/s10620-013-2920-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
23 Okamoto R, Yamamoto K, Yabushita K, Okano N, Shimada N, Matsumura S, Mizuno M, Higashi T, Tsuji T. T cell repertoire in primary biliary cirrhosis: a common T cell clone and repertoire change after treatment. J Clin Immunol 2001;21:278-85. [PMID: 11506198 DOI: 10.1023/a:1010983325927] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
24 McFarlane IM, Bhamra MS, Kreps A, Iqbal S, Al-Ani F, Saladini-Aponte C, Grant C, Singh S, Awwal K, Koci K, Saperstein Y, Arroyo-Mercado FM, Laskar DB, Atluri P. Gastrointestinal Manifestations of Systemic Sclerosis. Rheumatology (Sunnyvale). 2018;8. [PMID: 30057856 DOI: 10.4172/2161-1149.1000235] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
25 Yang WH, Yu JH, Gulick T, Bloch KD, Bloch DB. RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA 2006;12:547-54. [PMID: 16484376 DOI: 10.1261/rna.2302706] [Cited by in Crossref: 105] [Cited by in F6Publishing: 112] [Article Influence: 6.6] [Reference Citation Analysis]
26 Rubio CA. Qualitative and quantitative differences between bile ducts in chronic hepatitis and in primary biliary cirrhosis. J Clin Pathol 2000;53:765-9. [PMID: 11064670 DOI: 10.1136/jcp.53.10.765] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
27 Harada K, Nakanuma Y. Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol. 2006;39:55-61. [PMID: 16821141 DOI: 10.1007/s00795-006-0321-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kamradt T, Schubert D. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res Ther 2005;7:20-8. [PMID: 15642150 DOI: 10.1186/ar1476] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
29 Omagari K, Hazama H, Kohno S. Enzyme inhibition assay for pyruvate dehydrogenase complex: Clinical utility for the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2005; 11(43): 6735-6739 [PMID: 16425376 DOI: 10.3748/wjg.v11.i43.6735] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Honda S, Sawada K, Hasebe T, Nakajima S, Fujiya M, Okumura T. Tegafur-uracil-induced rapid development of advanced hepatic fibrosis. World J Gastroenterol 2017; 23(31): 5823-5828 [PMID: 28883709 DOI: 10.3748/wjg.v23.i31.5823] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
31 Gaj P, Habior A, Mikula M, Ostrowski J. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Med Genet 2008;9:81. [PMID: 18715515 DOI: 10.1186/1471-2350-9-81] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
32 Howel D, Metcalf JV, Gray J, Newman WL, Jones DE, James OF. Cancer risk in primary biliary cirrhosis: a study in northern England. Gut 1999;45:756-60. [PMID: 10517916 DOI: 10.1136/gut.45.5.756] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
33 Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol 2015; 7(7): 926-941 [PMID: 25954476 DOI: 10.4254/wjh.v7.i7.926] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
34 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(12): 1478-1481 [DOI: 10.11569/wcjd.v13.i12.1478] [Reference Citation Analysis]
35 Yu JH, Yang WH, Gulick T, Bloch KD, Bloch DB. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 2005;11:1795-802. [PMID: 16314453 DOI: 10.1261/rna.2142405] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
36 Li CH, Xu PS, Wang CY, Zhang Y, Zou GL. The presence of anti-mitochondrial antibodies in Chinese patients with liver involvement in systemic lupus erythematosus. Rheumatol Int 2006;26:697-703. [PMID: 16609870 DOI: 10.1007/s00296-005-0034-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Bateson MC, Gedling P. Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival. Postgrad Med J 1998;74:482-5. [PMID: 9926123 DOI: 10.1136/pgmj.74.874.482] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
38 Zhang H, Li P, Wu D, Xu D, Hou Y, Wang Q, Li M, Li Y, Zeng X, Zhang F. Serum IgG subclasses in autoimmune diseases. Medicine (Baltimore). 2015;94:e387. [PMID: 25590841 DOI: 10.1097/md.0000000000000387] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
39 Selmi C, Ichiki Y, Invernizzi P, Podda M, Gershwin ME. The enigma of primary biliary cirrhosis. Clin Rev Allergy Immunol 2005;28:73-81. [PMID: 15879614 DOI: 10.1385/CRIAI:28:2:073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Bloch DB, Nakajima A, Gulick T, Chiche JD, Orth D, de La Monte SM, Bloch KD. Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol 2000;20:6138-46. [PMID: 10913195 DOI: 10.1128/MCB.20.16.6138-6146.2000] [Cited by in Crossref: 109] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
41 Rachima CM, Cohen E, Garty M. Acute Hepatitis A: Combination of the Relapsing and the Cholestatic Forms, Two Rare Variants. The American Journal of the Medical Sciences 2000;319:417-9. [DOI: 10.1016/s0002-9629(15)40785-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
42 Invernizzi P, De Andreis C, Sirchia SM, Battezzati PM, Zuin M, Rossella F, Perego F, Bignotto M, Simoni G, Podda M. Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol. 2000;122:418-422. [PMID: 11122249 DOI: 10.1046/j.1365-2249.2000.01381.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
43 Durazzo M, Premoli A, Fagoonee S, Pellicano R. Overlap syndromes of autoimmune hepatitis: what is known so far. Dig Dis Sci 2003;48:423-30. [PMID: 12757152 DOI: 10.1023/a:1022597210629] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Watanabe T, Soga K, Hirono H, Hasegawa K, Shibasaki K, Kawai H, Aoyagi Y. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis. World J Gastroenterol 2009; 15(2): 231-239 [PMID: 19132775 DOI: 10.3748/wjg.15.231] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
45 Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci. 2006;51:1607-1613. [PMID: 16937077 DOI: 10.1007/s10620-006-9544-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
46 Fukushima N, Nalbandian G, Van De Water J, White K, Ansari AA, Leung P, Kenny T, Kamita SG, Hammock BD, Coppel RL, Stevenson F, Ishibashi H, Gershwin ME. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC: Characterization of Recombinant Monoclonal IgA Anti-PDC-E2 Autoantibodies Derived From Patients With PBC. Hepatology 2002;36:1383-92. [DOI: 10.1002/hep.1840360614] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Sasaki M, Ikeda H, Kataoka H, Nakanuma Y. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis. Virchows Arch. 2006;449:462-471. [PMID: 16941151 DOI: 10.1007/s00428-006-0257-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
48 Liberopoulos EN, Florentin M, Elisaf MS, Mikhailidis DP, Tsianos E. Fenofibrate in primary biliary cirrhosis: a pilot study. Open Cardiovasc Med J. 2010;4:120-126. [PMID: 20556204 DOI: 10.2174/1874192401004010120] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
49 Fuentealba IC, Aburto EM. Animal models of copper-associated liver disease. Comp Hepatol 2003;2:5. [PMID: 12769823 DOI: 10.1186/1476-5926-2-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
50 Mankaï A, Manoubi W, Ghozzi M, Melayah S, Sakly W, Ghedira I. High frequency of antiphospholipid antibodies in primary biliary cirrhosis. J Clin Lab Anal 2015;29:32-6. [PMID: 24687920 DOI: 10.1002/jcla.21723] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
51 Park BC, Park SM, Choi EY, Chae HB, Yoon SJ, Sung R, Lee SK. A case of idiopathic adulthood ductopenia. Korean J Intern Med. 2009;24:270-273. [PMID: 19721865 DOI: 10.3904/kjim.2009.24.3.270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol 2011;1:177-84. [PMID: 25755383 DOI: 10.1016/S0973-6883(11)60235-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
53 Palmer JM, Diamond AG, Yeaman SJ, Bassendine MF, Jones DE. T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC). Clin Exp Immunol 1999;116:133-9. [PMID: 10209517 DOI: 10.1046/j.1365-2249.1999.00803.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
54 Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest. 1998;102:1831-1840. [PMID: 9819369 DOI: 10.1172/jci4213] [Cited by in Crossref: 179] [Cited by in F6Publishing: 88] [Article Influence: 7.5] [Reference Citation Analysis]
55 Patel A, Seetharam A. Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. J Clin Exp Hepatol. 2016;6:311-318. [PMID: 28003721 DOI: 10.1016/j.jceh.2016.10.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
56 Sasaki M, Nakanuma Y. Novel approach to bile duct damage in primary biliary cirrhosis: participation of cellular senescence and autophagy. Int J Hepatol. 2012;2012:452143. [PMID: 21994884 DOI: 10.1155/2012/452143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
57 Reshetnyak VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol 2015; 21(25): 7683-7708 [PMID: 26167070 DOI: 10.3748/wjg.v21.i25.7683] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
58 Lee EY, Song C. Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol. Allergy Asthma Clin Immunol 2021;17:75. [PMID: 34294117 DOI: 10.1186/s13223-021-00578-7] [Reference Citation Analysis]
59 Danzer C, Mattner J. Impact of microbes on autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2013;61:175-86. [PMID: 23417246 DOI: 10.1007/s00005-013-0216-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
60 Tsangaridou E, Polioudaki H, Sfakianaki R, Samiotaki M, Tzardi M, Koulentaki M, Panayotou G, Kouroumalis E, Castanas E, Theodoropoulos PA. Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods. BMC Gastroenterol. 2010;10:28. [PMID: 20205958 DOI: 10.1186/1471-230x-10-28] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
61 Tamura S, Sugawara Y, Kaneko J, Togashi J, Matsui Y, Yamashiki N, Kokudo N, Makuuchi M. Recurrence of cholestatic liver disease after living donor liver transplantation. World J Gastroenterol 2008; 14(33): 5105-5109 [PMID: 18777585 DOI: 10.3748/wjg.14.5105] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
62 Allocca M, Crosignani A, Gritti A, Ghilardi G, Gobatti D, Caruso D, Zuin M, Podda M, Battezzati PM. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut. 2006;55:1795-1800. [PMID: 16632556 DOI: 10.1136/gut.2005.079814] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
63 Kubota J, Ikeda F, Terada R, Kobashi H, Fujioka S, Okamoto R, Baba S, Morimoto Y, Ando M, Makino Y, Taniguchi H, Yasunaka T, Miyake Y, Iwasaki Y, Yamamoto K. Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population. J Gastroenterol 2009;44:1000-6. [PMID: 19562250 DOI: 10.1007/s00535-009-0090-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
64 Marasini B, Gagetta M, Rossi V, Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001;60:1046-9. [PMID: 11602476 DOI: 10.1136/ard.60.11.1046] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
65 Jorquera F, Almar M, Linares A, Olcóz JL, Rodrigo L, González-Gallego J. Antipyrine clearance and metabolite formation in primary biliary cirrhosis. Dig Dis Sci 2001;46:352-9. [PMID: 11281185 DOI: 10.1023/a:1005661117739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
66 Mohr L, Heintges T, Hensel F, Niederau C, Häussinger D. Treatment of autoimmune cholangitis. Dig Dis Sci 1998;43:2160-3. [PMID: 9753287 DOI: 10.1023/a:1018840105188] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
67 Sasaki M, Ikeda H, Sato Y, Nakanuma Y. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol 2006;169:831-45. [PMID: 16936260 DOI: 10.2353/ajpath.2006.051237] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
68 Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000;38:1072-6. [PMID: 10698999 DOI: 10.1128/JCM.38.3.1072-1076.2000] [Cited by in Crossref: 172] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
69 Tsiveriotis K, Tsirogianni A, Pipi E, Soufleros K, Papasteriades C. Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis 2011;2011:626495. [PMID: 21687647 DOI: 10.4061/2011/626495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
70 Chung HV, Riley M, Ho JK, Leung B, Jevon GP, Arbour LT, Barker C, Schreiber R, Yoshida EM. Retrospective review of pediatric and adult autoimmune hepatitis in two quaternary care centres in British Columbia: increased prevalence seen in British Columbia's First Nations community. Can J Gastroenterol 2007;21:565-8. [PMID: 17853950 DOI: 10.1155/2007/757906] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
71 Schöniger-Hekele M, Müller C, Ackermann J, Drach J, Wrba F, Penner E, Ferenci P. Lack of evidence for involvement of fetal microchimerism in pathogenesis of primary biliary cirrhosis. Dig Dis Sci 2002;47:1909-14. [PMID: 12353828 DOI: 10.1023/a:1019623418063] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
72 Muratori L, Muratori P, Zauli D, Grassi A, Pappas G, Rodrigo L, Cassani F, Lenzi M, Bianchi FB. Antilactoferrin antibodies in autoimmune liver disease. Clin Exp Immunol. 2001;124:470-473. [PMID: 11472410 DOI: 10.1046/j.1365-2249.2001.01524.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
73 Razafindrazoto CI, Rakotozafindrabe ALR, Randriamifidy NH, Rasolonjatovo AS, Rabenjanahary TH, Razafimahefa SH, Ramanampamonjy RM. Primary biliary cholangitis-autoimmune hepatitis overlap syndrome: Case report and literature review. Clin Case Rep 2021;9:1647-50. [PMID: 33768907 DOI: 10.1002/ccr3.3861] [Reference Citation Analysis]
74 Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut. 2001;48:397-402. [PMID: 11171832 DOI: 10.1136/gut.48.3.397] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 4.4] [Reference Citation Analysis]
75 Vleggaar FP, van Buuren HR, Zondervan PE, ten Kate FJ, Hop WC; Dutch Multicentre PBC study group. Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant. Gut 2001;49:276-81. [PMID: 11454806 DOI: 10.1136/gut.49.2.276] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
76 Longo M, Crosignani A, Battezzati PM, Squarcia Giussani C, Invernizzi P, Zuin M, Podda M. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut. 2002;51:265-269. [PMID: 12117892 DOI: 10.1136/gut.51.2.265] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 6.2] [Reference Citation Analysis]
77 Moreira RK, Chopp W, Washington MK. The concept of hepatic artery-bile duct parallelism in the diagnosis of ductopenia in liver biopsy samples. Am J Surg Pathol 2011;35:392-403. [PMID: 21317711 DOI: 10.1097/PAS.0b013e3182082ef6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]